Health · 41 views
Weekly cisplatin fails to show fewer serious side effects in p16-negative head and neck cancer
Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer.
Summary
Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer. However, before NRG-HN009, there was limited randomized evidence to determine which regimen provided the best balance of cancer control and treatment-related side effects. This question is particularly important for patients with p16-negative disease, who often have multiple other health conditions and may have a lower tolerance for intensive chemoradiation.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Bayer reaches Roundup settlement that could cost the company billionsContinue reading
- New structures come into view in brain wiring mapsContinue reading
- Cigarettes on silver platters at Bondi ‘clean’ beauty business lip gloss launch referred for investigationContinue reading
- Stress and anxiety are wearing workers down: How to spot your triggers and copeContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow